Georgia records 67% decline in prevalence of Hepatitis C over previous years

In Georgia, Deputy Health Minister Tamar Gabunia stated on Thursday, March 24, that the prevalence of Hepatitis C has declined by 67 per cent as compared to previous years.

Gabunia stated in her remarks that antiviral therapies for the Hepatitis C virus have resulted in a 97 per cent recovery rate among Georgians, which she described as “a direct indication” that the Hepatitis C Elimination Program has been “extremely effective” throughout the years.

Georgia initiated the Hepatitis C Elimination Programme back in 2015, collaborating with the American biopharmaceutical company Gilead.

Currently, about 77,000 people are enrolled in the programme.

Georgia is one of the countries with the highest hepatitis C prevalence. In 2015, around 150,000 Georgians, or 5.4 per cent of the country’s adult population, were infected with HCV. The majority of infections are among men between the ages of 30 and 60 years.

New infections continue to emerge, primarily among people who inject drugs (PWID); nonetheless, risky health practices such as failing to thoroughly screen all blood donors for hepatitis C and inadequate infection control in healthcare settings may continue to put some Georgians at risk.

Georgia has received technical assistance from the Centers for Disease Control and Prevention (CDC) to help them achieve many strategic goals defined in the Strategic Plan for the Elimination of Hepatitis C Virus in Georgia. 

These six strategies include:

a) advocating for hepatitis C-related resource mobilisation through advocacy, education, and partnerships;

b) preventing HCV transmission;

c) identifying HCV-infected individuals;

d) improving hepatitis C laboratory diagnostics; 

e) providing hepatitis C care and treatment; and 

f) improving hepatitis C surveillance.

Georgia has put in place a variety of programmes and policies, identified problems and solutions for overcoming a barrier, and invested the resources necessary to keep moving forward toward its elimination targets. More than 36,000 patients living with hepatitis C had been cured in Georgia as of April 2019.

What is Hepatitis C?

Hepatitis C is an infection caused by a virus that attacks the liver and leads to inflammation. The disease is spread by contaminated blood by sharing needles or by unsterile tattoo equipment. The majority of persons show no signs or symptoms. Those who do experience symptoms may experience weariness, nausea, loss of appetite, and skin and eye yellowing. Antiviral medicine is used to treat hepatitis C. Newer treatments can help some patients get rid of the virus.


Zurab Kvaratskhelia

Recent Posts

Georgia: National cinema centre announces competition for films

The National Cinema Center of Georgia has announced a competition for financial support of a…

16 hours ago

Legendary Bullet Shooter Vakhtang Salukvadze Passes Away

The Georgian National Olympic Committee mourns on passing of the famous athlete and esteemed coach,…

16 hours ago

Ambrolauri: Council working meeting for disabled persons held

In Ambrolauri Municipality City Hall of Georgia a Working meeting of the Council on Persons…

16 hours ago

Tserovani Village Roads Undergo Major Upgrades

To enhance infrastructure and ensure safer mobility for residents, the village of Tserovani in Mtskheta…

17 hours ago

Tbilisi: Mayor inspects restoration-rehabilitation works of the State Silk Museum

Kakha Kaladze the Mayor of the Tbilisi city hall visited the site of the restoration-rehabilitation…

18 hours ago

Ambrolauri Hosts Meeting with Racha-Lechkhumi and Lower Svaneti

The Ambrolauri recently hosted a working meeting with the Racha-Lechkhumi and Lower Svaneti Women's Organization…

18 hours ago